Axogen’s Aim: Growing Tampa Into a Hub for Nerve Repair Treatment Technology
As a biotech company at the forefront of nerve repair treatment, UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, has always been near the front of the scientific curve.
Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced it has entered into a licensing agreement with the National Research Council of Canada (NRC) that will enable Oragenics to pursue the rapid development of next-generation vaccines against the SARS-CoV-2 virus and its variants.
AxoGen’s Avance Nerve Graft Helps Woman Race Horses Again
Woman returns to horse racing after AxoGen’s Avance nerve graft relieved her excruciating foot pain caused by osteoarthritis and surgeries.
DiaCarta Q&A: Liquid Biopsy for Early Cancer Detection
DiaCarta is initiating a large-scale clinical development program, which will monitor cfDNA levels to determine early treatment outcomes of systemic therapy in all types of stage IV cancer.
Axogen, Inc. Appoints John H. Johnson to Board of Directors
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that John H. Johnson has been appointed to its Board of Directors.
The Key to Life Is Learning | Dr. Ian White Founder of Neobiosis
Dr. Ian White, founder, president and chief scientific officer of UF Innovate | Sid Martin Biotech resident Neobiosis, a CDMO developing new drug applications with the FDA, producing therapeutic regenerative medicine products for human use, is featured on The Huxley Morton Podcast.
Experimental Skin Cancer Vaccine Developed in Tampa Saves Woman’s Life
A vaccine developed by Morphogenesis, Inc., a UF startup and UF Innovate | Sid Martin Biotech alum, helped improve a patients condition.
RTI Surgical and Exactech Announce Strategic Partnership
UF startup and UF Innovate | Sid Martin Biotech alum RTI Surgical Holdings, Inc., a leading surgical implant company providing blue-chip OEM customers with a portfolio of tissue-based, synthetic and metal implants, has announced it has entered into a long-term strategic agreement with Gainesville-based and leading global medical device OEM Exactech, related to the development and supply of biologic bone substitutes.
AGTC Reports 12-Month Data From Its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients With Mutations in the ACHM
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, reported 12-month data from its ongoing achromatopsia (ACHM) Phase 1/2 clinical trials, including data from all adult patients and low-dose pediatric patients.
As Director of UF Innovate’s Incubation Services, Mark Long ‘Got Stuff Done’
UF Innovate is saying goodbye to the man who wrote the book on business incubation. Mark Long, the author of several such books, has directed UF Innovate’s two business incubators, Sid Martin Biotech and The Hub, since January 2016. He will retire on June 30. “Mark’s positive, ‘get stuff done’ attitude – along with his […]